AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Research and development, 2025
- $183M
- YoY, 2025
- −2.0%
- 5-year CAGR
- +21.1%
- 10-year CAGR
- +39.1%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $183M | −2.0% |
| 2024 | $187M | +91.0% |
| 2023 | $98M | +69.0% |
| 2022 | $58M | −0.2% |
| 2021 | $58M | −17.3% |
| 2020 | $70M | +30.9% |
| 2019 | $54M | +128.3% |
| 2018 | $23M | +17.7% |
| 2017 | $20M | −5.9% |
| 2016 | $21M | +212.8% |
| 2015 | $6.8M | +58.4% |
| 2014 | $4.3M | — |